New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Waters Corporation
WAT
Shape
US Flag

NYSE

24B

Medical - Diagnostics & Research

Next Earning date - 12 Feb 2025

24B

Medical - Diagnostics & Research

Next Earning date - 12 Feb 2025

404.00USD
Shape-1.43 ( -0.35%)
Market Open
favorite-chart

Relative Strenght

82
favorite-chart

Volume Buzz

-28%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated January 19, 2025
1W 1.03 % 1M 9.73 % 3M 16.93 % 1Y 27.42 %

Key Metrics

Shape
  • Market Cap

    23.99B


  • Shares Outstanding

    59.38M


  • Share in Float

    59.33M


  • Dividende

    0


  • Earning Date

    12 Feb 2025


  • Price Target

    404


  • Average Volume

    501108


  • Beta

    0.973


  • Range

    279.24-411.58


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.waters.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

WAT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape319%

2025-Revenue

$12.85

Shape373%

2025-EPS

$1B

Shape300%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Bernstein

upgrade

Previous: Not converted

2025-01-10

Now: Outperform

Jefferies

upgrade

Previous: Not converted

2024-10-08

Now: Buy

Wells Fargo

initialise

Previous: Not converted

2024-08-27

Now: Overweight

Leerink Partners

upgrade

Previous: Not converted

2024-08-01

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+5%

3.84
vs 3.67

Q2.23

arrow
arrow

-11%

2.49
vs 2.8

Q3.23

arrow
arrow

+2%

2.8
vs 2.75

Q3.23

arrow
arrow

+3%

2.84
vs 2.75

Q4.23

arrow
arrow

-6%

3.62
vs 3.84

Q1.24

arrow
arrow

N/A

2.21
vs NA

Q2.24

arrow
arrow

+6%

2.63
vs 2.49

Q3.24

arrow
arrow

+3%

2.93
vs 2.84

Q4.24

arrow
arrow

+11%

4.03
vs 3.62

Q1.25

arrow
arrow

+9%

2.42
vs 2.21

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+3%

858.5M  vs 836.4M

Q2.23

arrow
arrow

-1%

684.7M  vs 690.6M

Q3.23

arrow
arrow

+4%

740.6M  vs 714.3M

Q3.23

arrow
arrow

0%

711.7M  vs 714.3M

Q4.23

arrow
arrow

-5%

819.5M  vs 858.5M

Q1.24

arrow
arrow

NA

636.8M  vs NA

Q2.24

arrow
arrow

+3%

708.5M  vs 684.7M

Q3.24

arrow
arrow

+4%

740.3M  vs 711.7M

Q4.24

arrow
arrow

+5%

856.6M  vs 819.5M

Q1.25

arrow
arrow

+6%

675.2M  vs 636.8M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+45%

0.45
vs 0.4

Q2.23

arrow
arrow

+23%

0.23
vs 0.45

Q3.23

arrow
arrow

+20%

0.2
vs 0.23

Q3.23

arrow
arrow

+15%

0.15
vs 0.2

Q4.23

arrow
arrow

+19%

0.19
vs 0.15

Q1.24

arrow
arrow

+8%

0.08
vs 0.19

Q2.24

arrow
arrow

+10%

0.1
vs 0.08

Q3.24

arrow
arrow

+10%

0.1
vs 0.1

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

661

661
vs 646

2%

Q1.23

arrow
arrow

685

685
vs 661

4%

Q2.23

arrow
arrow

657

657
vs 685

-4%

Q3.23

arrow
arrow

665

665
vs 657

1%

Q4.23

arrow
arrow

689

689
vs 665

4%

Q1.24

arrow
arrow

700

700
vs 689

2%

Q2.24

arrow
arrow

699

699
vs 700

0%

Q3.24

arrow
arrow

702

702
vs 699

0%

Earnings Growth

Latest News